News

GlaxoSmithKline plc announced the filing of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking an additional indication for the use…
Read More...

Immunocore Limited announces it has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery collaboration. Genentech and…
Read More...

Ampersand Capital Partners announced that it has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company NEOMED-LABS. This merger brings together…
Read More...

Innovus Pharmaceuticals announced today that the Company has acquired four branded topical products from Boston Topicals, expanding its retail and e-commerce presence in the Company’s…
Read More...

Merck KGaA, Darmstadt, Germany and software company Palantir Technologies announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower…
Read More...

Roivant Sciences and iNtRON Biotechnology announced that they have entered into a global licensing agreement for SAL200, a novel investigational biologic for the treatment of infectious…
Read More...

CASI Pharmaceuticals announces that it has entered into framework agreements to build a state-of-the-art manufacturing site strategically located in the Wuxi Huishan Economic…
Read More...

DirectBiologics, LLC announces the acquisition of Paisley Laboratories, LLC. The mission of these combined research and development companies is to transform regenerative healing with…
Read More...

Boehringer Ingelheim and Epizyme announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors directed toward two…
Read More...

Seattle Genetics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ADCETRIS (brentuximab vedotin) for previously untreated…
Read More...

Mission Therapeutics and AbbVie announced a collaboration in the research and preclinical development of specified DUB inhibitors for the treatment of Alzheimer’s Disease and…
Read More...

AstraZeneca has agreed to sell US rights to Synagis (palivizumab) used for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV)…
Read More...

Nexus Pharmaceuticals announced the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals’ Arsenic Trioxide Injection is available as 10mg…
Read More...

Adynxx and twoXAR announced an agreement to develop an oral, non-hormonal drug therapy with the potential to address the underlying mechanisms of endometriosis and significantly improve…
Read More...

Five Prime Therapeutics announced it initiated patient dosing in a Phase 1 clinical trial of FPT155, a first-in-class CD80 fusion protein. The trial was initiated in Australia. “We…
Read More...

Lonza announced the appointment of Allen Burgenson, Global Subject Matter Expert for Endotoxin Detection at Lonza, as Chair of the Horseshoe Crab Advisory Panel of the Atlantic States…
Read More...

Grünenthal announced that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be…
Read More...

Dragonfly Therapeutics announced it entered into a new agreement with Celgene Corporation and its affiliates to discover, develop and commercialize innovative immunotherapies for…
Read More...

AbbVie announced new data for its pan-genotypic chronic hepatitis C virus (HCV) treatment, MAVYRET (glecaprevir/pibrentasvir), in treatment-naïve patients with compensated cirrhosis.…
Read More...

Catalent Pharma Solutions announced its plans to invest $2.5 million in a new, second clinical supply facility in Shanghai, China, due to open in early 2019. When completed, the…
Read More...